Drug
Jtt 662
Jtt 662: highest development phase Phase 1, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| JTT-662 NCT04465877 | Phase 1 | Diabetes Mellitus, Type 2 |
Latest
No recent events.
Follow Jtt 662 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.